Grove Announces Name, Symbol Change to Upexi, ‘UPXI’, Effective Aug. 17, 2022
Grove Inc. (NASDAQ:GRVI), a market leader in Amazon and eCommerce brand ownership and aggregation, announces that today, August 17, 2022, its trading name on the Nasdaq officially changed from "Grove Inc."
Synopsys Q3 Adj. EPS $2.10 Up From $1.81 YoY, Sales $1.25B Beat $1.23B Estimate
Synopsys (NASDAQ:SNPS) reported quarterly earnings of $2.10 per share. This is a 16.02 percent increase over earnings of $1.81 per share from the same period last year. The company reported quarterly sales of $1.25
ObsEva Q2 EPS $(0.39) Misses $(0.19) Estimate
ObsEva (NASDAQ:OBSV) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.19) by 105.26 percent. This is a 39.29 percent decrease over losses of $(0.28) per share from the
‘DOE publishes list of EVs eligible for new tax credit’ -Teslarati
https://www.teslarati.com/doe-publishes-list-of-evs-eligible-for-new-tax-credit/
Pasithea Therapeutics Shares Move Higher On Increased Volume, Traders Circulate Benzinga Article Highlighting Co.’s Multiple Sclerosis Vaccine Efficacy Potential For Monkeypox; BZ Note: Article In Circulation Was Published 6 Days Ago
https://www.benzinga.com/general/biotech/22/08/28448364/exclusive-pasitheas-multiple-sclerosis-vaccine-candidate-shows-efficacy-in-animal-studies-with-po
‘Bluebird wins U.S. approval for a gene therapy to treat patients with a rare blood disorder’ -STAT
https://www.statnews.com/2022/08/17/bluebird-wins-fda-approval-for-gene-therapy-for-beta-thalassemia/?utm_content=bufferba14a&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic
Top 15 Trending Stocks On WallStreetBets As Of Monday, August 15, 2022 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Bed Bath & Beyond (BBBY)
GameStop (GME)
Tesla (TSLA)
Walmart (WMT)
Apple (AAPL)
AMC Entertainment (AMC)
Tilray Brands
Charah Solutions Q2 Adj. EPS $(0.34) Misses $(0.21) Estimate, Sales $77.11M Miss $79.48M Estimate
Charah Solutions (NYSE:CHRA) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.21) by 61.9 percent. This is a 70 percent decrease over losses of $(0.20) per share from the